Laryngeal Squamous Cell Carcinoma

general

A squamous cell carcinoma that arises from the larynx. It is the most common histologic type of laryngeal carcinoma. It can arise from the glottis, supraglottic area, or it can be transglottic. Glottic squamous cell carcinoma is the most frequent laryngeal carcinoma in the United States. The symptoms, clinical behavior and the prognosis depend on the site of origin within the larynx.

82

Centers

449

Active Trials

$3.8B

Cancer Funding

Specific Cancer Types(9)

Top Centers for Laryngeal Squamous Cell Carcinoma(82)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.9
2
NCI Comprehensive
Active Research Program
66.2
3
NCI Comprehensive
Active Research Program
66.2
4
NCI Comprehensive
Active Research Program
66.2
5
NCI Comprehensive
Active Research Program
66.2
666.2
7
NCI Comprehensive
Active Research Program
66.2
8
NCI Comprehensive
Active Research Program
66.2
9
NCI Comprehensive
Active Research Program
66.2
10
NCI Comprehensive
Active Research Program
66.2
11
NCI Comprehensive
Active Research Program
66.2
12
Active Research Program
66.2
13
NCI Comprehensive
Active Research Program
66.2
14
Active Research Program
66.2
15
NCI Comprehensive
Active Research Program
66.2
16
Active Research Program
66.2
17
Active Research Program
66.2
18
NCI Comprehensive
Active Research Program
66.2
19
Active Research Program
66.2
20
Active Research Program
66.2
21
Active Research Program
66.2
22
NCI Comprehensive
Active Research Program
48.2
23
NCI Comprehensive
Active Research Program
48.2
24
NCI Comprehensive
Active Research Program
48.2
25
NCI Comprehensive
Active Research Program
48.2
26
NCI Comprehensive
Active Research Program
48.2
27
NCI Comprehensive
Active Research Program
48.2
28
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
48.2
29
NCI Comprehensive
Active Research Program
48.2
30
NCI Comprehensive
Active Research Program
48.2
31
NCI Comprehensive
Active Research Program
48.2
32
NCI Comprehensive
Active Research Program
48.2
33
NCI Comprehensive
Active Research Program
48.2
34
NCI Comprehensive
Active Research Program
48.2
35
NCI Comprehensive
Active Research Program
48.2
36
NCI Clinical
Active Research Program
48.2
37
NCI Comprehensive
Active Research Program
48.2
38
Active Research Program
48.2
39
NCI Comprehensive
Active Research Program
48.2
40
NCI Comprehensive
Active Research Program
48.2
41
NCI Clinical
Active Research Program
48.2
42
NCI Comprehensive
Active Research Program
48.2
43
NCI Comprehensive
Active Research Program
48.2
44
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
48.2
45
NCI Clinical
Active Research Program
48.2
46
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
48.2
4748.2
48
Active Research Program
48.2
49
Active Research Program
48.2
50
NCI Basic_laboratory
Active Research Program
48.2
51
Active Research Program
48.2
52
Active Research Program
48.2
53
Active Research Program
48.2
54
Active Research Program
48.2
55
Active Research Program
48.2
56
Active Research Program
48.2
57
Active Research Program
48.2
58
Active Research Program
48.2
59
NCI Comprehensive
32.3
60
NCI Comprehensive
32.3
61
NCI Comprehensive
32.3
62
NCI Comprehensive
32.3
63
NCI Comprehensive
32.3
64
NCI Comprehensive
32.3
6532.3
66
NCI Clinical
32.3
67
NCI Comprehensive
32.3
68
Cedars-Sinai CancerLos Angeles, CA
32.3
6932.3
7032.3
7132.3
72
NCI Comprehensive
73
74
NCI Comprehensive
75
NCI Comprehensive
76
77
78
NCI Clinical
79
80
81
82
BC CancerVancouver, BC

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →